BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7410844)

  • 1. Genetic control of sensitivity to Moloney leukemia virus in mice. IV. Phenotypic heterogeneity of the leukemic mice.
    Boyer B; Gisselbrecht S; Debre P; McKenzie I; Levy JP
    J Immunol; 1980 Oct; 125(4):1415-20. PubMed ID: 7410844
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence and phenotypic heterogeneity of Moloney virus-induced leukemias: a multigenic control.
    Debre P; Gisselbrecht S; Boyer B; Levy JP
    Blood Cells; 1981; 7(2):301-11. PubMed ID: 6975141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic control of sensitivity to Moloney leukemia virus in mice. III. The three H-2 linked Rmv genes are immune response genes controlling the antiviral antibody response.
    Debré P; Boyer B; Gisselbrecht S; Bismuth A; Lévy JP
    Eur J Immunol; 1980 Dec; 10(12):914-8. PubMed ID: 6781910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic control of sensitivity to Moloney leukemia virus in mice. II. Mapping of three resistant genes within the H-2 complex.
    Debre P; Gisselbrecht S; Pozo F; Levy JP
    J Immunol; 1979 Oct; 123(4):1806-12. PubMed ID: 479600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic control of murine leukemias induced by Moloney virus].
    Debré P; Gisselbrecht S; Boyer B; Lévy JP
    Bull Cancer; 1982; 69(2):178-87. PubMed ID: 6812667
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenotypic heterogeneity of Moloney leukemia virus-induced T cel lymphomas.
    Pepersack L; Lee JC; McEwan R; Ihle JN
    J Immunol; 1980 Jan; 124(1):279-85. PubMed ID: 6965293
    [No Abstract]   [Full Text] [Related]  

  • 8. Properties of murine leukemia-associated suppressor cells. I. Preferential suppression of thymus-dependent antibody responses and the requirement for syngeneity in the K region of the H-2 complex.
    Grinwich KD; Alexander TS; Cerny J
    J Immunol; 1979 Mar; 122(3):1108-15. PubMed ID: 376703
    [No Abstract]   [Full Text] [Related]  

  • 9. A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.
    Stukart MJ; Vos A; Boes J; Melvold RW; Bailey DW; Melief CJ
    J Immunol; 1982 Mar; 128(3):1360-4. PubMed ID: 6799575
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo studies of increased incidence of sister chromatid exchanges in target cells of replication-component Friend murine leukemia virus.
    Palitti F; Matarese GP; Diana G; Sorrentino V; Rossi GB
    Cancer Res; 1982 Nov; 42(11):4753-7. PubMed ID: 7127311
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathogenesis of Rauscher leukemia in aggregation chimeras of the BALB/C----C57BL/6 mouse].
    Fedorov LM; Klepikov NN; Koniukhov BV
    Izv Akad Nauk SSSR Biol; 1986; (4):561-70. PubMed ID: 3745637
    [No Abstract]   [Full Text] [Related]  

  • 12. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-2D control of radiation leukemia virus induced neoplasia: evidence for interaction of viral and H-2 genomic information.
    Meruelo D; Kramer J
    Transplant Proc; 1981 Dec; 13(4):1858-62. PubMed ID: 6277058
    [No Abstract]   [Full Text] [Related]  

  • 14. Total lymphoid irradiation (TLI) and allogeneic marrow transplantation for enzyme replacement therapy and immunotherapy of leukemia in mice.
    Slavin S; Yatziv S; Weiss L; Morecki S; Abeliuk P; Fuks Z
    Transplant Proc; 1981 Mar; 13(1 Pt 1):439-42. PubMed ID: 7022868
    [No Abstract]   [Full Text] [Related]  

  • 15. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
    Atencio IA; Belli B; Hobbs M; Cheng SF; Villarreal LP; Fan H
    Virology; 1995 Oct; 212(2):356-66. PubMed ID: 7571405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic and immunochemical studies of the cell membrane alloantigens of K36, an AKR spontaneous leukemia.
    Schmidt W; Festenstein H; Atfield G
    Transplant Proc; 1980 Mar; 12(1):29-31. PubMed ID: 7368291
    [No Abstract]   [Full Text] [Related]  

  • 17. Interleukin-6 in myeloma/plasmacytoma.
    Suematsu S; Matsusaka T; Matsuda T; Hirano T; Kishimoto T
    Int Rev Exp Pathol; 1993; 34 Pt A():91-8. PubMed ID: 8454420
    [No Abstract]   [Full Text] [Related]  

  • 18. A new gene that controls the type of leukemia induced by Friend murine leukemia virus.
    Silver JE; Fredrickson TN
    J Exp Med; 1983 Aug; 158(2):493-505. PubMed ID: 6577128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of viral and cellular recombinational events in murine leukemia.
    Fischinger PJ; Dunlop NM; Dekaban GA; Robey WG
    Transplant Proc; 1984 Apr; 16(2):428-34. PubMed ID: 6326352
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of a Moloney lymphoma with cyclophosphamide and H-2-incompatible spleen cells.
    Fefer A
    Cancer Res; 1973 Apr; 33(4):641-4. PubMed ID: 4696464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.